title: Time for reappraisal of progesterone-receptor testing in breast cancer management.
authors.forename: Gaëtan
authors.initials: G
authors.lastname: MacGrogan
authors.forename: Isabelle
authors.initials: I
authors.lastname: de Mascarel
authors.forename: Ghyslaine
authors.initials: G
authors.lastname: Sierankowski
authors.forename: Louis
authors.initials: L
authors.lastname: Mauriac
authors.forename: Marc
authors.initials: M
authors.lastname: Debled
authors.forename: Michel
authors.initials: M
authors.lastname: Durand
authors.forename: Christine Tunon
authors.initials: CT
authors.lastname: De Lara
authors.forename: Antoine
authors.initials: A
authors.lastname: Avril
authors.forename: Véronique
authors.initials: V
authors.lastname: Picot
authors.forename: Simone
authors.initials: S
authors.lastname: Mathoulin-Pélissier
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D010347:Patient Care Planning; D011237:Predictive Value of Tests; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone